Biofidelity launches Aspyre® Lung Reagents, now enabling integrated tissue and liquid biopsy analysis
recent articles
Article in Nature Communications demonstrates that with 96% sensitivity, AI diagnostic MSIntuit™ CRC can rule out almost half of the MSS population of colorectal cancer patients unlikely to respond to checkpoint...
A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to new research led by investigators at the Bloomberg~Kimmel...
Indica Labs has announced their 9th Annual HALO® User Group Meeting in London Indica Labs’ London HALO® User Group Meeting Date: 6 December 2023 Time: 12:00 – 16:00 Location: InterContinental London (the O2) REGISTER NOW Learn...
Cytomine is thrilled to invite you to visit our company's booth at the upcoming Carrefour Pathologie Conference 2023, which takes place from 22 November until 24 November at the CNIT Forest Paris-La-Défense in Paris, France. Cytomine has...
GE Healthcare: New data supports the potential role of Artificial Intelligence (AI) in predicting patients’ response to immunotherapies in advance of their treatment. November 2, 2023 — GE HealthCare’s Artificial Intelligence (AI)...
Lunit: Six posters featuring the Lunit SCOPE suite and new insights into the tumor microenvironment are to be showcased at the SITC 2023 Annual Meeting SEOUL, South Korea, Nov. 1, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading...
